• Home

IAVI Portfolio

Our science, pursued with many partners, focuses on:

  • Discovery and development of vaccine candidates capable of eliciting broadly neutralizing antibodies (bNAbs) to prevent HIV infection.
  • Discovery and development of replicating viral vector-based vaccine candidates capable of preventing and controlling HIV infection.
  • Providing product development services to the broader AIDS vaccine field to help advance the most promising candidates into clinical development.

Portfolio February 2017